Fig. 1From: Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonatesRelation of a heart rate (r2 = 0.031, p = 0.04), b respiratory rate (r2 = 0.001, p = 0.68), c episodes of apnea (r2 < 0.001, p = 0.97) recorded during the physical exam in the day of TDM as a function of caffeine serum concentration. Note: b · min−1, beats per minute; br · min−1, breaths per minuteBack to article page